Your browser doesn't support javascript.
loading
Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base.
Ortega, Hector; Hahn, Beth; Bogart, Michael; Bell, Christopher F; Bancroft, Tim; Chastek, Benjamin; Llanos, Jean-Pierre.
Afiliação
  • Ortega H; From the Clinical Development, Gossamer Bio, San Diego, California.
  • Hahn B; US Value Evidence and Outcomes, US Medical Affairs, GSK, Research Triangle Park, North Carolina.
  • Bogart M; US Value Evidence and Outcomes, US Medical Affairs, GSK, Research Triangle Park, North Carolina.
  • Bell CF; US Value Evidence and Outcomes, US Medical Affairs, GSK, Research Triangle Park, North Carolina.
  • Bancroft T; Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota; and.
  • Chastek B; Health Economics and Outcomes Research, Optum, Eden Prairie, Minnesota; and.
  • Llanos JP; Global Medical Affairs, Amgen, Thousand Oaks, California.
Allergy Asthma Proc ; 41(5): 341-347, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32867888
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Etiology_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: America do norte Idioma: En Ano de publicação: 2020 Tipo de documento: Article